Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Fulcrum Therapeutics (FULC) has disclosed Receivables - Net for 3 consecutive years, with $13000.0 as the latest value for Q3 2022.

  • On a quarterly basis, Receivables - Net changed N/A to $13000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $13000.0, a N/A change, with the full-year FY2021 number at $2.5 million, up 25.0% from a year prior.
  • Receivables - Net was $13000.0 for Q3 2022 at Fulcrum Therapeutics, down from $357000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $2.5 million in Q4 2021 to a low of $13000.0 in Q3 2022.
  • A 3-year average of $1.2 million and a median of $1.2 million in 2020 define the central range for Receivables - Net.
  • Biggest YoY gain for Receivables - Net was 25.0% in 2021; the steepest drop was 25.0% in 2021.
  • Fulcrum Therapeutics' Receivables - Net stood at $2.0 million in 2020, then rose by 25.0% to $2.5 million in 2021, then plummeted by 99.48% to $13000.0 in 2022.
  • Per Business Quant, the three most recent readings for FULC's Receivables - Net are $13000.0 (Q3 2022), $357000.0 (Q2 2022), and $2.5 million (Q4 2021).